Benjamin Edwards’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$229K Sell
2,650
-341
-11% -$30.3K ﹤0.01% 1348
2026
Q2
$271K Sell
2,991
-4,891
-62% -$410K ﹤0.01% 1278
2026
Q1
$631K Buy
7,882
+123
+2% +$10.1K 0.01% 909
2025
Q4
$661K Buy
7,759
+105
+1% +$8.62K 0.01% 853
2025
Q3
$595K Buy
7,654
+901
+13% +$70.4K 0.01% 876
2025
Q2
$528K Buy
6,753
+721
+12% +$53.8K 0.01% 834
2025
Q1
$437K Sell
6,032
-13,136
-69% -$940K 0.01% 828
2024
Q4
$1.42M Buy
19,168
+3,844
+25% +$269K 0.02% 509
2024
Q3
$1.01M Buy
15,324
+15,106
+6,929% +$1.1M 0.01% 600
2024
Q2
$20K Buy
218
+37
+20% +$3.28K ﹤0.01% 587
2024
Q1
$17K Buy
+181
New +$15.2K ﹤0.01% 590

Other funds holding EW

Benjamin Edwards's EW Position: Q3 2026 in Review

Benjamin Edwards reduced its Edwards Lifesciences (EW) stake by 11% in Q3 2026, selling an estimated $30.3K and leaving 2,650 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1348.

Benjamin Edwards first reported a position in EW in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.42M in Q4 2024. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Benjamin Edwards held 2,650 shares of Edwards Lifesciences worth $229K as of Q3 2026.
  • Benjamin Edwards sold 341 Edwards Lifesciences shares in Q3 2026, an estimated $30.3K.
  • Edwards Lifesciences made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1348 holding.
  • Benjamin Edwards first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 11 quarters since.
  • Benjamin Edwards's Edwards Lifesciences position peaked at $1.42M in Q4 2024.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.